Human Gene Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.6 | Q1 | 80.7% | 1.282 | Q1 | 89.4% |
| 2024 | 4.0 | Q1 | 78.0% | 1.137 | Q2 | 87.2% |
| 2023 | 3.9 | Q2 | 66.9% | 1.091 | Q2 | 87.5% |
| 2022 | 4.2 | Q1 | 66.9% | 1.045 | Q2 | 87.2% |
| 2021 | 4.8 | Q2 | 70.3% | 1.163 | Q2 | 89.4% |
| 2020 | — | — | 1.633 | Q1 | 93.5% | |
| 2019 | — | — | 1.648 | Q1 | 93.8% | |
| 2018 | — | — | 1.731 | Q1 | 93.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1557-7422
ISSN
1043-0342
region
Northern America
coverage
1990-2026